JP2006166711A - Simple amplification method for stool-derived genes - Google Patents
Simple amplification method for stool-derived genes Download PDFInfo
- Publication number
- JP2006166711A JP2006166711A JP2004359468A JP2004359468A JP2006166711A JP 2006166711 A JP2006166711 A JP 2006166711A JP 2004359468 A JP2004359468 A JP 2004359468A JP 2004359468 A JP2004359468 A JP 2004359468A JP 2006166711 A JP2006166711 A JP 2006166711A
- Authority
- JP
- Japan
- Prior art keywords
- gene
- stool
- solution
- filter paper
- amplification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 78
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 44
- 230000003321 amplification Effects 0.000 title claims description 24
- 238000003199 nucleic acid amplification method Methods 0.000 title claims description 24
- 230000004544 DNA amplification Effects 0.000 claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 17
- 238000000926 separation method Methods 0.000 claims abstract description 5
- 210000003608 fece Anatomy 0.000 claims description 17
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 claims description 10
- 238000000123 temperature gradient gel electrophoresis Methods 0.000 claims description 10
- 244000005700 microbiome Species 0.000 claims description 9
- 201000010099 disease Diseases 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 238000000018 DNA microarray Methods 0.000 claims description 5
- 101000829171 Hypocrea virens (strain Gv29-8 / FGSC 10586) Effector TSP1 Proteins 0.000 claims description 5
- 108010052285 Membrane Proteins Proteins 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 5
- 238000009396 hybridization Methods 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 239000002683 reaction inhibitor Substances 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 abstract description 13
- 108020004707 nucleic acids Proteins 0.000 abstract description 12
- 102000039446 nucleic acids Human genes 0.000 abstract description 12
- 238000000746 purification Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 38
- 108020004414 DNA Proteins 0.000 description 20
- 238000005119 centrifugation Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 206010009944 Colon cancer Diseases 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000002550 fecal effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 101150105104 Kras gene Proteins 0.000 description 4
- 102000018697 Membrane Proteins Human genes 0.000 description 4
- 101150048834 braF gene Proteins 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 210000005170 neoplastic cell Anatomy 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 101150014006 thrA gene Proteins 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 238000007399 DNA isolation Methods 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 238000007397 LAMP assay Methods 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108020001027 Ribosomal DNA Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 238000001821 nucleic acid purification Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 208000014081 polyp of colon Diseases 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108700042226 ras Genes Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
【課題】従来のように糞便からの核酸を分離精製することなく、簡便に目的とする遺伝子を増幅する方法を確立、提供する。
【解決手段】(a)溶解液で糞便を溶解する工程、(b)該溶解液を濾紙に含ませる工程、(c)得られた濾紙を直接、遺伝子増幅反応溶液に接触させ、遺伝子増幅を行う工程、を含む方法による。糞便に含まれる核酸を濾紙を用いて分離、吸着させ、該濾紙を遺伝子増幅反応に直接用いることができるので、従来のように核酸分離精製を経ることなく、簡便に効率よく糞便中の目的遺伝子を増幅させることができる。
【選択図】なしThe present invention establishes and provides a method for easily amplifying a target gene without separating and purifying nucleic acid from stool as in the prior art.
SOLUTION: (a) a step of dissolving stool with a solution, (b) a step of including the solution in a filter paper, (c) contacting the obtained filter paper directly with a gene amplification reaction solution to carry out gene amplification. Performing the method. Nucleic acids contained in stool can be separated and adsorbed using filter paper, and the filter paper can be used directly for gene amplification reaction, so that the target gene in stool can be easily and efficiently passed without nucleic acid separation and purification as in the past Can be amplified.
[Selection figure] None
Description
本発明は、ほ乳類の糞便から核酸精製を経ることなく、目的とする遺伝子を核酸増幅反応により簡便に増幅する方法である。 The present invention is a method for simply amplifying a target gene by a nucleic acid amplification reaction from nucleic acid stool without nucleic acid purification.
ほ乳類の糞便中に存在する、腸内細菌叢や病原性細菌、ウイルス、又はその他ほ乳類の消化管粘膜細胞、悪性新生物細胞、新生物細胞、及び分泌液に存在する遺伝子断片を用いて、各種類の疾患の原因探求や診断に用いることは、個体の健康状態の把握や悪性新生物の早期発見のために非常に有用である。しかしながら、糞便中の遺伝子を分離精製する技術は煩雑で手間がかかるのが現状である。 Using intestinal flora and pathogenic bacteria, viruses, or other digestive tract mucosal cells, malignant neoplastic cells, neoplastic cells, and gene fragments present in the secretions of mammals, It is very useful for investigating the cause of various types of diseases and for diagnosing the disease, for the purpose of grasping the health condition of individuals and early detection of malignant neoplasms. However, the current technology for separating and purifying genes in stool is complicated and time-consuming.
現状の解析手段として、例えば、病原性細菌を同定したい場合は、対象となる試料(個体の糞便)を希釈液で希釈し、これを種々の選択培地上に撒き、嫌気性培養を行う必要があった。しかし、培養の際には数日から数週間の時間を要することとなり、コロニー数のカウント等操作も煩雑であった。 For example, when it is desired to identify pathogenic bacteria as current analysis means, it is necessary to dilute the target sample (individual stool) with a diluent, spread it on various selective media, and perform anaerobic culture. there were. However, the culture takes several days to several weeks, and operations such as counting the number of colonies are complicated.
これに対し、近年になって、分子生物学的手法を用いた系統分類・同定法が信頼できる手法として注目を集めている。各種遺伝子を標的とした、特異的なプローブ・プライマーによって、幅広い種の細菌の迅速かつ特異的な検出が可能となり、これらは微生物の検出において鍵となる技術になりつつある。特に特異的PCRプライマーを用いた方法は、簡便・迅速・正確に目的とする細菌の検出・同定を行うことができる。 On the other hand, in recent years, phylogenetic classification and identification methods using molecular biological methods have attracted attention as reliable methods. Specific probes and primers targeting various genes enable rapid and specific detection of a wide variety of bacteria, which are becoming key technologies in the detection of microorganisms. In particular, the method using a specific PCR primer can detect / identify a target bacterium simply, rapidly and accurately.
また、糞便中に存在する悪性新生物細胞の遺伝子変異を同定することにより、例えば大腸癌などのスクリーニングを行う有用性が指摘されている(非特許文献1)。 Further, it has been pointed out that the utility of screening for colon cancer, for example, by identifying genetic mutations in malignant neoplastic cells present in feces (Non-patent Document 1).
糞便からのDNAの単離は、アルカリ性の溶解液に糞便を溶解し、遠心分離、及びアルコール沈澱により単離する方法が一般的である。 In general, DNA is isolated from stool by dissolving the stool in an alkaline lysate, followed by centrifugation and alcohol precipitation.
また、微生物からのDNAの単離は、これまでは、試料をリン酸緩衝液(PBS)等で洗浄し、塩化ベンジル法により菌体を破砕・蛋白質変性してアルコール沈殿することにより行われていた。しかしこの方法では、グラム陽性球菌などの一部の細菌からはほとんどDNAを回収できないことが指摘されている。 In the past, DNA from microorganisms has been isolated by washing the sample with phosphate buffer (PBS) or the like, crushing the cells using the benzyl chloride method, denaturing the protein, and precipitating with alcohol. It was. However, it has been pointed out that this method hardly recovers DNA from some bacteria such as Gram-positive cocci.
また、最近では、試料からのDNA単離の際、直径0.1mm程度のビーズを加えてフェノール存在下で激しく振とうすることにより菌体を破砕する方法が広く用いられるようになっており、この方法によれば、多岐にわたる種の細菌から効率よくDNAを単離することができる(非特許文献2)。 In addition, recently, when isolating DNA from a sample, a method of crushing bacterial cells by adding beads with a diameter of about 0.1 mm and shaking vigorously in the presence of phenol has been widely used. According to the method, DNA can be efficiently isolated from a wide variety of bacteria (Non-patent Document 2).
しかしながら、糞便には、PCR等の増幅反応において、反応を阻害する物質(腐敗酸等)が含まれていることがわかっており、これらの方法ではこの阻害物質の除去に問題があると考えられている。 However, it is known that feces contain substances that inhibit the reaction (such as spoilage acid) in amplification reactions such as PCR, and it is considered that these methods have problems in removing these inhibitors. ing.
DNA単離用キットの市販品として、MagExtractor(東洋紡製)やQIAamp Stool DNA Isolation Kit(QIAGEN製)が販売されている。前者はビーズで菌体を破砕した後、ビーズに吸着したDNAを磁気ビーズで回収するものであるが、DNAの収率が悪いという問題がある。一方、後者は加熱により菌体膜タンパクを変性させ、DNAを単離するものであるが、やはりこの方法によっても収率に問題がある。 As commercial products for DNA isolation, MagExtractor (manufactured by Toyobo) and QIAamp Stool DNA Isolation Kit (manufactured by QIAGEN) are sold. The former involves crushing bacterial cells with beads and then recovering the DNA adsorbed on the beads with magnetic beads, but there is a problem in that the yield of DNA is poor. On the other hand, the latter is to denature cell membrane proteins by heating to isolate DNA, but this method also has a problem in yield.
また、ビーズとゲル濾過を用いることにより核酸を抽出する方法もある(特許文献1)が、作業工程の複雑さ、直接作業性の悪化を避けることはできない。 There is also a method of extracting nucleic acids by using beads and gel filtration (Patent Document 1), but the complexity of the work process and the deterioration of direct workability cannot be avoided.
また、乾燥濾紙便を用いて糞便からの核酸抽出を行う方法(特許文献2)は、以下の(1)〜(4)の工程を必要とする。 Moreover, the method (patent document 2) which performs nucleic acid extraction from feces using dry filter paper stool requires the following steps (1) to (4).
(1)乾燥便を濾紙と共にマイクロチューブに取り、DNA分解酵素の阻害剤としてEDTAを、また陰イオン多塘体のイオン対除去のための陽イオン性界面活性剤;セチルトリメチルアンモニウムブロミド(以下CTAB)を含む高塩濃度の抽出用溶液を加え煮沸(ボイル)処理を行う。
(2)次にクロロホルムを加え混合後、遠心分離を行うことにより、陰イオン多糖体-CTAB対、過剰のCTAB、便残渣成分と濾紙は下層のクロロホルム層に、目的のDNA溶液は上層の水層へと分離する。
(3)得られた水層を新たなチューブに分取し、再度、クロロホルムによる抽出操作を繰返して得られた水層に2-プロパノールを加えて遠心後、DNAの沈澱を得る。
(4)70%のエタノールで沈澱を洗浄後、トリス緩衝液-EDTA溶液を加えて最終的なDNA溶液を得る。
(1) Take dried stool in a microtube together with filter paper, EDTA as an inhibitor of DNA-degrading enzyme, and a cationic surfactant for removing ion pairs of anionic polymorphs; cetyltrimethylammonium bromide (hereinafter CTAB) ) And a high salt concentration extraction solution is added to perform boiling.
(2) Next, after adding chloroform and mixing, the mixture is centrifuged to remove the anionic polysaccharide-CTAB pair, excess CTAB, fecal residue components and filter paper in the lower chloroform layer, and the target DNA solution in the upper water layer. Separate into layers.
(3) The obtained aqueous layer is collected in a new tube, and 2-propanol is added to the aqueous layer obtained by repeating extraction with chloroform again, followed by centrifugation to obtain a DNA precipitate.
(4) After washing the precipitate with 70% ethanol, a Tris buffer-EDTA solution is added to obtain a final DNA solution.
このように、糞便からDNAを分離精製すること自体が、煩雑で実用性には乏しいレベルに留まっている。
本発明が解決しようとする課題は糞便からDNAを従来のように分離精製することなく、簡便に目的とする遺伝子を増幅する方法を確立、提供することにある。 The problem to be solved by the present invention is to establish and provide a method for simply amplifying a target gene without separating and purifying DNA from stool in the conventional manner.
上記課題を解決するために本発明者らは、糞便を溶解液に溶解させ、該溶解液を濾紙に含ませ、反応を阻害する物質及びその糞便に含まれる核酸を濾紙に含ませて分離、吸着させ、該濾紙を直接PCR反応に用いることによって、糞便に含まれる核酸を従来の核酸分離精製工程を経ることなく、目的とする遺伝子を簡便に効率良く増幅させる本発明の方法を完成した。 In order to solve the above problems, the present inventors dissolved feces in a solution, and included the solution in filter paper, and separated the substance that inhibits the reaction and the nucleic acid contained in the feces into the filter paper, By adsorbing and using the filter paper directly in the PCR reaction, the nucleic acid contained in the stool was completed easily and efficiently without a conventional nucleic acid separation and purification step.
すなわち、本発明は、以下からなる。
1.以下の工程を含む、糞便から得られる遺伝子の増幅方法:
(a)溶解液で糞便を溶解する工程;
(b)糞便を溶解した溶液を濾紙に含ませる工程;
(c)得られた濾紙を直接、遺伝子増幅反応溶液に接触させ、遺伝子増幅を行う工程。
2.工程(a)で得られた糞便を溶解した溶液を、微生物の膜タンパクを変性させるために処理する前項1の方法。
3.工程(b)によって、糞便を溶解した溶液中の増幅反応阻害物質と遺伝子を分離する前項1の方法。
4.前項1〜3の増幅方法の工程(c)において、目的の遺伝子の特異的プライマーを用いてPCRを行うことにより目的の遺伝子を同定する、糞便中に存在する遺伝子の解析方法。
5.前項1〜3の増幅方法により得られた遺伝子増幅産物を用いて、DNAチップによるハイブリダイゼーション、クローンライブラリー法、変性グラジェンドゲル電気泳動法(DGGE法)、温度グラジェンドゲル電気泳動法(TGGE)法、又はSSCP法により、疾患関連遺伝子を検出・同定する方法。
6.前項1〜3の増幅方法により得られた遺伝子増幅産物を用いて、DNAチップによるハイブリダイゼーション、クローンライブラリー法、変性グラジェンドゲル電気泳動法(DGGE法)、温度グラジェンドゲル電気泳動法(TGGE)法、又はSSCP法により、微生物を特異的に検出・同定する方法。
7.前項1〜3の増幅方法を行うための少なくとも以下の構成を含む試薬キット:
(1)糞便溶解用の溶液;
(2)遺伝子分離用濾紙。
That is, this invention consists of the following.
1. A method for amplifying a gene obtained from stool comprising the following steps:
(A) a step of dissolving feces with a solution;
(B) including a solution in which feces are dissolved in filter paper;
(C) A step of performing gene amplification by directly contacting the obtained filter paper with a gene amplification reaction solution.
2. The method according to item 1 above, wherein the solution obtained by dissolving the stool obtained in step (a) is treated to denature the membrane protein of the microorganism.
3. The method according to item 1 above, wherein the amplification reaction inhibitor and the gene in the solution in which stool is dissolved are separated by the step (b).
4). 4. A method for analyzing a gene present in feces, wherein the target gene is identified by performing PCR using a specific primer of the target gene in the step (c) of the amplification method according to items 1 to 3.
5. Using the gene amplification product obtained by the amplification method of 1 to 3 above, hybridization using a DNA chip, clone library method, denaturing gradient gel electrophoresis (DGGE method), temperature gradient gel electrophoresis (TGGE) ) Method or SSCP method to detect and identify disease-related genes.
6). Using the gene amplification product obtained by the amplification method of 1 to 3 above, hybridization using a DNA chip, clone library method, denaturing gradient gel electrophoresis (DGGE method), temperature gradient gel electrophoresis (TGGE) ) Method or SSCP method to specifically detect and identify microorganisms.
7). Reagent kit including at least the following components for performing the amplification method according to items 1 to 3 above:
(1) Solution for stool dissolution;
(2) Filter paper for gene separation.
本発明の方法によれば、糞便から、核酸を従来のように分離精製することなく、簡便に目的とする遺伝子をPCR等の増幅反応により増幅することが可能となる。 According to the method of the present invention, it is possible to easily amplify a target gene from feces by an amplification reaction such as PCR without separating and purifying nucleic acid as in the prior art.
本発明において、糞便とは、ほ乳類より得られる排泄物である。糞便には腸粘膜細胞、血液細胞、腸内細胞叢、病原微生物(例えば細菌やウィルス)、腸内新生組織(大腸癌やポリープを含む)などが存在する。本発明において遺伝子とは、糞便中に含まれる各種疾患関連遺伝子や微生物関連遺伝子を示しており、例えば遺伝病等の原因遺伝子、大腸癌組織由来遺伝子、又は細菌由来遺伝子等が挙げられる。 In the present invention, stool is excrement obtained from mammals. Feces include intestinal mucosal cells, blood cells, intestinal cell flora, pathogenic microorganisms (eg, bacteria and viruses), intestinal neoplasia (including colon cancer and polyps), and the like. In the present invention, genes refer to various disease-related genes and microbial-related genes contained in feces, and examples include causative genes such as genetic diseases, colon cancer tissue-derived genes, or bacteria-derived genes.
[工程(a)]
本発明においては、まず、糞便の溶解を行う。この工程は糞便に含まれる固形物を溶解するために行う。糞便の溶解液は公知のものを用いることができる。例えば、Tris-EDTAバッファーや8.4%(1M)炭酸水素ナトリウム溶液等を利用することができる。好ましくはTris-EDTAバッファーを含むpH値が9前後の溶液を用いることができる。溶解液の添加量は、溶解する糞便1mgに対し、0.1〜100μL、好ましくは1〜30μL、より好ましくは3〜7μL前後が望ましい。腸内細菌等の微生物の遺伝子を目的とする場合には、微生物の膜タンパクを変性させることもできる。膜タンパクを変性させるためには、例えば、溶解液に糞便を溶解したのちに、加熱処理(例えば60〜95℃、10分間〜10時間)を行えばよい。
[Step (a)]
In the present invention, first, stool is dissolved. This step is performed to dissolve the solid matter contained in the stool. A known stool solution can be used. For example, a Tris-EDTA buffer or 8.4% (1M) sodium hydrogen carbonate solution can be used. Preferably, a solution containing a Tris-EDTA buffer and having a pH value of about 9 can be used. The addition amount of the lysis solution is desirably 0.1 to 100 μL, preferably 1 to 30 μL, more preferably around 3 to 7 μL per 1 mg of stool to be dissolved. When a gene of a microorganism such as an enteric bacterium is aimed, the membrane protein of the microorganism can be denatured. In order to denature the membrane protein, for example, stool is dissolved in a solution, and then heat treatment (for example, 60 to 95 ° C., 10 minutes to 10 hours) may be performed.
[工程(b)]
次いで、糞便を溶解した溶液を濾紙に含ませる。遠心分離を行わずにそのまま工程(a)で得られた溶解液に、直接濾紙を接触させてもよいが、適宜遠心分離を行った後、得られる上澄み液に濾紙を接触させる方がより好ましい。遠心分離は、3000〜8000rpm、好ましくは4000〜6000rpm、より好ましくは5,000rpm前後の回転数で1分から5分間の間で適宜行えばよい。
[Step (b)]
Next, a solution in which stool is dissolved is included in the filter paper. The filter paper may be directly contacted with the lysate obtained in the step (a) without performing centrifugation, but it is more preferable to contact the filter paper with the supernatant obtained after appropriate centrifugation. . Centrifugation may be suitably performed at a rotational speed of 3000 to 8000 rpm, preferably 4000 to 6000 rpm, more preferably around 5,000 rpm, for 1 minute to 5 minutes.
使用する濾紙は保留粒子径1〜7μmが望ましい。また、ここで言う保留粒子径とはJIS P 3801 [ろ紙(化学分析用)]で規定された硫酸バリウムなどを、自然濾過したときの漏洩粒子径により求めたものを指す。また陰イオン交換能をつけた濾紙を用いてもよい。市販品としては、ADVANTEC社の標準濾紙2号、26号、及び高純度濾紙No.5B等が例示される。
濾紙の大きさは、試料となる溶液の量に依存するが、一般的には、縦10〜200mm、横1〜10mmの短冊形が用いられる。濾紙の厚さは、一般的に、0.2〜0.8mmである。
The filter paper to be used preferably has a retention particle diameter of 1 to 7 μm. The retained particle size referred to here refers to a value obtained from the leaked particle size when barium sulfate or the like specified in JIS P 3801 [filter paper (for chemical analysis)] is naturally filtered. Moreover, you may use the filter paper which attached the anion exchange ability. Examples of commercially available products include ADVANTEC standard filter paper No. 2 and No. 26, and high-purity filter paper No. 5B.
The size of the filter paper depends on the amount of the sample solution, but generally a rectangular shape having a length of 10 to 200 mm and a width of 1 to 10 mm is used. The thickness of the filter paper is generally 0.2 to 0.8 mm.
濾紙と溶解液との接触は、濾紙の先端部分の2〜10mmを溶液に0.5〜3秒間浸すことで行う。遠心分離を行った後、糞便を溶解した溶液に濾紙を浸す場合は、該溶液の上澄み液部分のみに接触させて、溶解液を含む濾紙を工程(c)の増幅反応に使用すればよい。また、遠心分離を行っていない糞便を溶解した溶液に濾紙を浸した場合は、糞便溶解液との接触で着色された濾紙の色が薄い上部分を、工程(c)の増幅反応に使用するのが好ましい。
濾紙に吸収された試料は、濾紙の表面張力によって自然展開され、遺伝子の分離が行われる。かくして、濾紙によって、溶液中に存在する増幅反応阻害物質、例えば腐敗酸等と遺伝子との分離を行うことができる。
所望により、濾紙の展開を高めるために、吸引条件下(例えば、真空ポンプ内)、ぶら下げ処理を行ってよい。展開は、室温で十分であるが、湿度40〜60%、温度15〜37℃で行うことがより好ましい。
The contact between the filter paper and the solution is performed by immersing 2 to 10 mm at the tip of the filter paper in the solution for 0.5 to 3 seconds. When the filter paper is immersed in a solution in which stool is dissolved after centrifugation, the filter paper containing the solution may be used for the amplification reaction in step (c) by contacting only the supernatant of the solution. In addition, when filter paper is immersed in a solution in which stool is not centrifuged, the upper part of the filter paper that is colored by contact with the stool solution is used for the amplification reaction in step (c). Is preferred.
The sample absorbed by the filter paper is naturally developed by the surface tension of the filter paper, and the genes are separated. Thus, the filter paper can be used to separate the gene from the amplification reaction inhibitor, such as rot acid, present in the solution.
If desired, a hanging process may be performed under suction conditions (eg, in a vacuum pump) to enhance the development of the filter paper. The expansion is sufficient at room temperature, but it is more preferable to carry out at a humidity of 40 to 60% and a temperature of 15 to 37 ° C.
[工程(c)]
次に遺伝子の増幅反応を行う。遺伝子増幅は、現在公知の方法を適用することができる。具体的には、ポリメラーゼ・チェイン・リアクション法(PCR法、Science, 230:1350-1354,1985)やNASBA法(Nucleic Acid Sequence Based Amplification 法、Nature, 350,91-92,1991)及びLAMP法(特開2001-242169号公報)等が挙げられ、好ましくはPCR法を適用することができる。以下では、PCR法を例示して説明をする。
工程(c)では、工程(b)により得られた濾紙を、増幅したい目的の遺伝子のプライマーを含んだPCR反応混合溶液に浸し、(i)数秒間、PCR反応混合溶液に濾紙を浸した後、濾紙を取り除きPCRを行う方法、及び(ii)工程(b)により得られた濾紙の必要な部分を切り出し、該切り出した濾紙をPCR反応混合溶液にいれたままPCRを行う方法の二通りが可能である。いずれの方法を用いるかは状況に応じて使い分けることが可能である。また、PCRバッファーとしてはAmpdirect粗精製DNA用バッファー(島津製作所)を用いることが好ましいが、広く公知のPCR用緩衝液を使用することができる。
[Step (c)]
Next, a gene amplification reaction is performed. Currently known methods can be applied to gene amplification. Specifically, polymerase chain reaction method (PCR method, Science, 230: 1350-1354, 1985), NASBA method (Nucleic Acid Sequence Based Amplification method, Nature, 350, 91-92, 1991) and LAMP method ( JP, 2001-242169, A) etc. are mentioned, Preferably PCR method can be applied. Hereinafter, the PCR method will be described as an example.
In step (c), immerse the filter paper obtained in step (b) in a PCR reaction mixture solution containing the primer of the gene of interest to be amplified, and (i) immerse the filter paper in the PCR reaction mixture solution for several seconds. There are two methods: a method of removing the filter paper and performing PCR, and a method of (ii) cutting out the necessary portion of the filter paper obtained in step (b) and performing the PCR while the cut filter paper is kept in the PCR reaction mixture solution. Is possible. Which method is used can be selected according to the situation. As the PCR buffer, it is preferable to use Ampdirect crude DNA buffer (Shimadzu Corporation), but widely known PCR buffers can be used.
本発明は、上記の方法において、得られた濾紙を使用し、特異的プライマーを用いて遺伝子増幅反応を行うことより、目的とする遺伝子を増幅した後、該遺伝子を検出・同定することも可能である。従って糞便中に存在する遺伝子、例えば、糞便中の腫瘍マーカー等の各種疾患関連遺伝子マーカーや微生物関連遺伝子の解析方法を提供することができる。 The present invention can detect and identify the gene after amplifying the target gene by performing the gene amplification reaction using the obtained filter paper in the above method and using a specific primer. It is. Therefore, it is possible to provide a method for analyzing genes present in stool, for example, various disease-related gene markers such as tumor markers in stool and microorganism-related genes.
更に、本発明の方法により得られた遺伝子増幅産物を用いて、DNAチップによるハイブリダイゼーションや、クローンライブラリー法、変性グラジェンドゲル電気泳動法(DGGE法)、温度グラジェンドゲル電気泳動法(TGGE)法、SSCP法を行うことにより、例えば、遺伝病や腫瘍等の各種疾患の検出、あるいは糞便中の微生物叢を構成する微生物を特異的に検出・同定することもできる。 Furthermore, using the gene amplification product obtained by the method of the present invention, hybridization using a DNA chip, clone library method, denaturing gradient gel electrophoresis (DGGE method), temperature gradient gel electrophoresis (TGGE) ) Method and SSCP method, for example, it is possible to detect various diseases such as genetic diseases and tumors, or to specifically detect and identify microorganisms constituting the microflora in feces.
なお本発明は、上記遺伝子増幅方法に用いることのできる糞便溶解用の溶液、遺伝子分離用濾紙を含む試薬キットにも及ぶものである。
以下に具体的な実施形態を示す。
The present invention extends to a fecal dissolution solution that can be used in the gene amplification method and a reagent kit including a gene separation filter paper.
Specific embodiments are shown below.
(実施例1)糞便溶解液を含む濾紙の作製
糞便の溶解液として,500mmol/L Tris-HCl, 16mmol/L EDTA,10mmol/L NaCl, pH9.0の組成の溶液(Lysisバッファー)を調製した。1.5mlチューブに糞便を100mg取り、Lysisバッファーを500μL入れ、糞便を溶解した。溶解する糞便20mgに対し、Lysisバッファーは100μL前後が望ましい。糞便を溶解した溶液を95℃-10分間加熱処理を行なった。5,000rpm-5分間遠心分離後,濾紙をその上澄み液につけた。本実施例では濾紙はADVANTEC社の標準濾紙2号を用いた。次に、上澄み液を含ませた濾紙を乾燥させ、その上澄み液を含んだ濾紙部分を直接PCR反応混合溶液に2〜3秒間浸け、軽く濯ぐことにより糞便中に存在するDNAをPCR反応混合溶液内に抽出した(図1〜6)。
(Example 1) Preparation of filter paper containing fecal solution A solution (Lysis buffer) having a composition of 500 mmol / L Tris-HCl, 16 mmol / L EDTA, 10 mmol / L NaCl, pH 9.0 was prepared as a fecal solution. . 100 mg of stool was taken in a 1.5 ml tube and 500 μL of Lysis buffer was added to dissolve the stool. About 20 μL of Lysis buffer is desirable for 20 mg of stool to be dissolved. The solution in which stool was dissolved was subjected to heat treatment at 95 ° C. for 10 minutes. After centrifugation at 5,000 rpm for 5 minutes, filter paper was applied to the supernatant. In this example, ADVANTEC standard filter paper No. 2 was used as the filter paper. Next, dry the filter paper containing the supernatant, immerse the filter paper containing the supernatant directly in the PCR reaction mixture for 2 to 3 seconds, and lightly rinse the DNA present in the stool for PCR reaction mixing. Extracted into the solution (FIGS. 1-6).
(実施例2)糞便中の遺伝子の増幅
実施例1による方法で得た濾紙を用いて、糞便に存在するKRAS遺伝子とBRAF遺伝子、及び大腸菌のthrA遺伝子の増幅を行った。糞便溶解溶液上澄み液の付着した濾紙部分を,(A)KRAS遺伝子コドン12,13を挟んで増幅するプライマーペアー(FK-F: 5'- TGACTGAATATAAACTTGTGGTAG, FK-106R: 5'- ATTGTTGGATCATATTCGTC)、(B)BRAF遺伝子コドン599を挟んで増幅するプライマーペアー(FB-F: 5'-TAGGTGATTTTGGTCTAGCT, FB-115R: 5'-ATCAGTGGAAAAATAGCCTC)、(C)大腸菌に特異的なThrA遺伝子を増幅するプライマーペアー(thrA-F: 5'- CCCCGCCAAAATCACCAACCATCT, thrA-101R: 5'- CGGCAAAAATACGTTCGGCATCG)、(D)(A)に記載のKRAS遺伝子を増幅するプライマーペアーと(B)に記載のBRAF遺伝子を増幅するプライマーペアーとを含むPCR反応混合溶液50μLに、各々浸けて濯ぎ、DNAを抽出した。(A)、(B)、(C)、(D)の各遺伝子増幅反応はすべて、アニーリング温度53℃の条件で40サイクルのPCR反応を行った。その後、3%アガロースゲルにて電気泳動を行い、目的とする遺伝子が増幅されていることを確認した(図5〜10)。
(Example 2) Amplification of gene in stool Using the filter paper obtained by the method of Example 1, the KRAS gene and BRAF gene present in stool and the thrA gene of Escherichia coli were amplified. (A) Primer pair (FK-F: 5'-TGACTGAATATAAACTTGTGGTAG, FK-106R: 5'- ATTGTTGGATCATATTCGTC), (B) ) Primer pair (FB-F: 5'-TAGGTGATTTTGGTCTAGCT, FB-115R: 5'-ATCAGTGGAAAAATAGCCTC), (C) Primer pair that amplifies ThrA gene specific for Escherichia coli (thrA-) F: 5'- CCCCGCCAAAATCACCAACCATCT, thrA-101R: 5'- CGGCAAAAATACGTTCGGCATCG), (D) including a primer pair that amplifies the KRAS gene described in (A) and a primer pair that amplifies the BRAF gene described in (B) DNA was extracted by rinsing each in 50 μL of the PCR reaction mixture solution. In each of the gene amplification reactions (A), (B), (C), and (D), 40 cycles of PCR reaction were performed under the condition of an annealing temperature of 53 ° C. Thereafter, electrophoresis was performed on a 3% agarose gel to confirm that the target gene was amplified (FIGS. 5 to 10).
本発明の方法を用いることにより糞便試料から従来のように核酸を精製・抽出することなく、極めて簡便に目的とする遺伝子の糞便からの増幅・検出が可能となる。よって、本発明を用いることにより、遺伝子診断、早期ガン診断、感染症診断が、従来よりも迅速かつ鋭敏に行うことが可能となる。本発明の実施例によると、正常粘膜組織由来DNA、及び正常粘膜組織由来DNAが大量に存在する条件下での微量の大腸癌組織由来DNAを検出することが本発明の方法により可能であることを示しただけでなく、細菌DNAの直接検出も本発明により可能であることを示した。よって、本発明を用いれば、極めて容易かつ確実に各種の糞便からの遺伝子診断を行うことができる。他の生体試料にはない特有の情報を有する糞便試料が非侵襲DNA材料として、実用的に簡便に利用可能となったことは、各種疾患の診断上有用であるばかりではなく、操作的に多数検体の処理を可能にする。従って、正常集団を対象とした大腸癌等の各種検診への応用も可能であり、また集団発症的な感染症などの原因を迅速に検出することも可能となる。本発明の方法は、近年、益々重要性が高まっている予防医学への貢献、及び集団発症を引き起こす感染症等の迅速な診断への応用が期待できる。 By using the method of the present invention, amplification and detection of a target gene from stool can be performed very easily without purifying and extracting nucleic acid from a stool sample as in the prior art. Therefore, by using the present invention, genetic diagnosis, early cancer diagnosis, and infectious disease diagnosis can be performed more rapidly and sensitively than before. According to the embodiment of the present invention, it is possible to detect a small amount of DNA derived from normal mucosal tissue and a small amount of colorectal cancer tissue DNA under conditions where a large amount of normal mucosal tissue-derived DNA exists. It was shown that direct detection of bacterial DNA is also possible with the present invention. Therefore, by using the present invention, genetic diagnosis from various stool can be performed extremely easily and reliably. The fact that fecal samples having unique information not found in other biological samples can be used practically and simply as non-invasive DNA materials is not only useful for diagnosis of various diseases, but also has many operations. Enables sample processing. Therefore, it can be applied to various types of examinations such as colorectal cancer targeting a normal population, and it is also possible to quickly detect causes such as mass-onset infections. The method of the present invention can be expected to contribute to preventive medicine, which has become increasingly important in recent years, and to be applied to rapid diagnosis of infectious diseases that cause mass onset.
Claims (7)
(a)溶解液で糞便を溶解する工程;
(b)糞便を溶解した溶液を濾紙に含ませる工程;
(c)得られた濾紙を直接、遺伝子増幅反応溶液に接触させ、遺伝子増幅を行う工程。 A method for amplifying a gene obtained from stool comprising the following steps:
(A) a step of dissolving feces with a solution;
(B) including a solution in which feces are dissolved in filter paper;
(C) A step of performing gene amplification by directly contacting the obtained filter paper with a gene amplification reaction solution.
(1)糞便溶解用の溶液;
(2)遺伝子分離用濾紙。 Reagent kit comprising at least the following components for performing the amplification method according to claims 1 to 3:
(1) Solution for stool dissolution;
(2) Filter paper for gene separation.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004359468A JP2006166711A (en) | 2004-12-13 | 2004-12-13 | Simple amplification method for stool-derived genes |
| PCT/JP2005/022676 WO2006064739A1 (en) | 2004-12-13 | 2005-12-09 | Method of treating biological sample for performing nucleic acid amplification |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004359468A JP2006166711A (en) | 2004-12-13 | 2004-12-13 | Simple amplification method for stool-derived genes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2006166711A true JP2006166711A (en) | 2006-06-29 |
Family
ID=36587795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004359468A Pending JP2006166711A (en) | 2004-12-13 | 2004-12-13 | Simple amplification method for stool-derived genes |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2006166711A (en) |
| WO (1) | WO2006064739A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015019952A1 (en) * | 2013-08-06 | 2015-02-12 | 東洋紡株式会社 | Method of amplifying nucleic acid |
| JP2020068725A (en) * | 2018-10-31 | 2020-05-07 | 公益財団法人筑波メディカルセンター | Sample pretreatment method |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011019505A (en) * | 2009-01-29 | 2011-02-03 | Mukogawa Gakuin | Method for detecting specific gene |
| JP5875230B2 (en) * | 2011-02-01 | 2016-03-02 | 健司 木下 | Gene amplification method, specific gene detection method |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4483920A (en) * | 1982-05-17 | 1984-11-20 | Hahnemann University | Immobilization of message RNA directly from cells onto filter material |
| JP2001078790A (en) * | 1989-03-23 | 2001-03-27 | Akzo Nobel Nv | Methods for isolating nucleic acids |
| JP2004201607A (en) * | 2002-12-26 | 2004-07-22 | Asahi Kasei Corp | LAMP reaction on nucleic acid-adsorbed solid phase |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993020235A1 (en) * | 1992-04-01 | 1993-10-14 | The Johns Hopkins University School Of Medicine | Methods of detecting mammalian nucleic acids isolated from stool specimen and reagents therefor |
| JP2001221721A (en) * | 2000-02-09 | 2001-08-17 | Sapporo Imuno Diagnostic Laboratory:Kk | Genetic diagnosis using dried filter paper stool |
| JP3779888B2 (en) * | 2001-04-11 | 2006-05-31 | 株式会社ヤクルト本社 | Nucleic acid isolation method |
-
2004
- 2004-12-13 JP JP2004359468A patent/JP2006166711A/en active Pending
-
2005
- 2005-12-09 WO PCT/JP2005/022676 patent/WO2006064739A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4483920A (en) * | 1982-05-17 | 1984-11-20 | Hahnemann University | Immobilization of message RNA directly from cells onto filter material |
| JP2001078790A (en) * | 1989-03-23 | 2001-03-27 | Akzo Nobel Nv | Methods for isolating nucleic acids |
| JP2004201607A (en) * | 2002-12-26 | 2004-07-22 | Asahi Kasei Corp | LAMP reaction on nucleic acid-adsorbed solid phase |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015019952A1 (en) * | 2013-08-06 | 2015-02-12 | 東洋紡株式会社 | Method of amplifying nucleic acid |
| JPWO2015019952A1 (en) * | 2013-08-06 | 2017-03-02 | 東洋紡株式会社 | Nucleic acid amplification method |
| JP2019068815A (en) * | 2013-08-06 | 2019-05-09 | 東洋紡株式会社 | Nucleic acid amplification method |
| JP2020068725A (en) * | 2018-10-31 | 2020-05-07 | 公益財団法人筑波メディカルセンター | Sample pretreatment method |
| JP7403948B2 (en) | 2018-10-31 | 2023-12-25 | 公益財団法人筑波メディカルセンター | Sample pretreatment method |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006064739A1 (en) | 2006-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1169479B1 (en) | Methods for detecting nucleic acids indicative of cancer | |
| ES2971094T3 (en) | Detection of one or more pathogens | |
| JP2023536085A (en) | Purification of sulfonated DNA | |
| US10323241B2 (en) | Method for recovering short-chain nucleic acids | |
| CN113278717A (en) | Primer pool, kit and method for detecting bloodstream infection by targeted sequencing method | |
| WO2000029618A1 (en) | Non-invasive detection of helicobacter pylori infection | |
| JP2006166711A (en) | Simple amplification method for stool-derived genes | |
| KR101912488B1 (en) | Molecular detection assay | |
| JP4765058B2 (en) | Sample pretreatment method before nucleic acid modification | |
| JP2001221721A (en) | Genetic diagnosis using dried filter paper stool | |
| JP3779888B2 (en) | Nucleic acid isolation method | |
| JP2022533269A (en) | Method for detecting rare DNA sequences in stool samples | |
| JP4431775B2 (en) | Method for detecting RNA derived from Cryptosporidium parvum | |
| JP4674073B2 (en) | Method for avoiding inhibition in nucleic acid amplification reaction | |
| WO2025012638A1 (en) | Detection method for mycobacteria | |
| Zhuang et al. | Advances in gene-targeted diagnostics for pathogenic Escherichia coli | |
| JPWO2007116450A1 (en) | Nucleic acid extraction method and nucleic acid extraction kit | |
| CN115418393A (en) | Excrement nucleic acid-free extraction sample releasing agent | |
| CN116590471A (en) | Detection device and method for detecting early-stage hepatitis B-to-liver cancer based on specific PCR | |
| JPWO2012014694A1 (en) | Method for synthesizing fecal nucleic acid | |
| JP2006094830A (en) | Microbial community analysis method | |
| JPH0965899A (en) | Oligonucleotide, primer for detecting Helicobacter pylori comprising the same, and method for detecting Helicobacter pylori using the same | |
| WO2010041444A1 (en) | Method for detecting integron, method for detecting integron pollution in the environment, and primer pair | |
| JP2007075018A (en) | Detection method of Campylobactercoli | |
| JPWO1997010359A1 (en) | Method for concentrating mutant nucleic acids and nucleic acid concentration test set for carrying out said concentration method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071207 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100810 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101206 |